Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase.
暂无分享,去创建一个
D. Reid | S. Ralston | A. Gödecke | M. Helfrich | K. E. Armour | K. Armour | M. E. Gallagher | M. Gallagher
[1] S. Ralston,et al. Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Reid,et al. Evidence for a Pathogenic Role of Nitric Oxide in Inflammation‐Induced Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] S. Ralston,et al. Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells. , 1999, Bone.
[4] J. Tobias,et al. High‐Dose Estrogen Induces De Novo Medullary Bone Formation in Female Mice , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] E H Burger,et al. Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent. , 1998, Biochemical and biophysical research communications.
[6] T Jämsä,et al. Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. , 1998, Bone.
[7] J. Chow,et al. Nitric oxide synthase expression in bone cells. , 1998, Bone.
[8] R. Pacifici. Editorial: Cytokines, Estrogen, and Postmenopausal Osteoporosis-The Second Decade. , 1998, Endocrinology.
[9] H. Bidmon,et al. Coronary hemodynamics in endothelial NO synthase knockout mice. , 1998, Circulation research.
[10] S. Ralston,et al. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. , 1998, Endocrinology.
[11] I. Owan,et al. Effects of nitric oxide synthase inhibitors on bone formation in rats. , 1997, Bone.
[12] R. Kimble,et al. The Functional Block of TNF but Not of IL‐6 Prevents Bone Loss in Ovariectomized Mice , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] S. Ralston,et al. Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. , 1996, Bone.
[14] L. Donahue,et al. Genetic variability in adult bone density among inbred strains of mice. , 1996, Bone.
[15] H. Tsukahara,et al. Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats. , 1996, The American journal of physiology.
[16] C. Yallampalli,et al. Nitric oxide donor alleviates ovariectomy-induced bone loss. , 1996, Bone.
[17] G. Murrell,et al. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. , 1996, The American journal of physiology.
[18] P. Nijweide,et al. Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts--correlation with prostaglandin upregulation. , 1995, Biochemical and biophysical research communications.
[19] A. Pitsillides,et al. Mechanical strain‐induced NO production by bone cells: a possible role in adaptive bone (re)modeling? , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] J. Polak,et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. , 1995, Endocrinology.
[21] P. W. Johnston,et al. Nitric oxide: A cytokine‐induced regulator of bone resorption , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] J M Polak,et al. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Riancho,et al. Expression and functional role of nitric oxide synthase in osteoblast‐like cells , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] R. Jilka,et al. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.
[25] S. Ralston,et al. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. , 1994, Endocrinology.
[26] I. Charles,et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Kasten,et al. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Nibbering,et al. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. , 1994, The Journal of clinical investigation.
[29] M. Lantry,et al. High‐dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] D. Peterson,et al. The non specificity of specific nitric oxide synthase inhibitors. , 1992, Biochemical and biophysical research communications.
[31] H. Datta,et al. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Barbagallo,et al. Histological evidence of increased turnover in bone from spontaneously hypertensive rats. , 1991, Cardioscience.
[33] E. Ritz,et al. Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. , 1989, Hypertension.
[34] A. Parfitt. Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system). , 1988, Bone.
[35] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[37] R. Pacifici. Cytokines, estrogen, and postmenopausal osteoporosis--the second decade. , 1998, Endocrinology.
[38] J. Pollock,et al. Expression of Nitric Oxide Synthase Isoforms in Bone and Bone Cell Cultures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] J. Poser,et al. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. , 1984, Metabolic bone disease & related research.